{"id":380047,"date":"2020-11-12T12:33:35","date_gmt":"2020-11-12T17:33:35","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=380047"},"modified":"2020-11-12T12:33:35","modified_gmt":"2020-11-12T17:33:35","slug":"lilly-to-participate-in-bernstein-operational-decisions-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/","title":{"rendered":"Lilly to Participate in Bernstein Operational Decisions Conference"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">INDIANAPOLIS<\/span>, <span class=\"xn-chron\">Nov. 12, 2020<\/span> \/PRNewswire\/ &#8212;\u00a0Eli Lilly and Company (NYSE:LLY) will participate in the Bernstein Operational Decisions Conference on <span class=\"xn-chron\">Monday, November 16, 2020<\/span>. <span class=\"xn-person\">Andrew Adams<\/span>, Ph.D., vice president of new therapeutic modalities and scientific leader for Lilly&#8217;s anti-COVID-19 platform, <span class=\"xn-person\">Jeff Emmick<\/span>, M.D., Ph.D., vice president of diabetes product development, and <span class=\"xn-person\">Mark Mintun<\/span>, M.D., vice president of pain and neurodegeneration research and president of Avid Radiopharmaceuticals, will participate in a virtual fireside chat at 11:00\u00a0a.m., Eastern Time. <\/p>\n<p>A live audio webcast will be available on the &#8220;Webcasts &amp; Presentations&#8221; section of Lilly&#8217;s Investor website at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2980248-1&amp;h=3771191873&amp;u=https%3A%2F%2Finvestor.lilly.com%2Fwebcasts-and-presentations&amp;a=https%3A%2F%2Finvestor.lilly.com%2Fwebcasts-and-presentations\" rel=\"nofollow noopener noreferrer\">https:\/\/investor.lilly.com\/webcasts-and-presentations<\/a>. A replay of the presentation will be available on this same website for approximately 90 days.<\/p>\n<p>\n        <b>About\u00a0Eli Lilly and Company<br \/><\/b>Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2980248-1&amp;h=4244126843&amp;u=http%3A%2F%2Fwww.lilly.com%2F&amp;a=www.lilly.com\" rel=\"nofollow noopener noreferrer\">www.lilly.com<\/a>. \u00a0F-LLY\u00a0\u00a0\u00a0 <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder3324\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg\" title=\"Eli Lilly and Company logo. (PRNewsfoto\/Eli Lilly and Company)\" alt=\"Eli Lilly and Company logo. (PRNewsfoto\/Eli Lilly and Company)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>Refer to:<\/b>\u00a0<br \/><span class=\"xn-person\">Mark Taylor<\/span>; <a target=\"_blank\" href=\"mailto:mark.taylor@lilly.com\" rel=\"nofollow noopener noreferrer\">mark.taylor@lilly.com<\/a>; (317) 276-5795 (Media)<br \/><span class=\"xn-person\">Kevin Hern<\/span>; <a target=\"_blank\" href=\"mailto:hern_kevin_r@lilly.com\" rel=\"nofollow noopener noreferrer\">hern_kevin_r@lilly.com<\/a>;\u00a0(317) 277-1838 (Investors)<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DE90166&amp;sd=2020-11-12\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/lilly-to-participate-in-bernstein-operational-decisions-conference-301172168.html\">http:\/\/www.prnewswire.com\/news-releases\/lilly-to-participate-in-bernstein-operational-decisions-conference-301172168.html<\/a><\/p>\n<p>SOURCE  Eli Lilly and Company<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DE90166&amp;Transmission_Id=202011121230PR_NEWS_USPR_____DE90166&amp;DateId=20201112\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire INDIANAPOLIS, Nov. 12, 2020 \/PRNewswire\/ &#8212;\u00a0Eli Lilly and Company (NYSE:LLY) will participate in the Bernstein Operational Decisions Conference on Monday, November 16, 2020. Andrew Adams, Ph.D., vice president of new therapeutic modalities and scientific leader for Lilly&#8217;s anti-COVID-19 platform, Jeff Emmick, M.D., Ph.D., vice president of diabetes product development, and Mark Mintun, M.D., vice president of pain and neurodegeneration research and president of Avid Radiopharmaceuticals, will participate in a virtual fireside chat at 11:00\u00a0a.m., Eastern Time. A live audio webcast will be available on the &#8220;Webcasts &amp; Presentations&#8221; section of Lilly&#8217;s Investor website at https:\/\/investor.lilly.com\/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days. About\u00a0Eli Lilly and CompanyLilly is a global &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lilly to Participate in Bernstein Operational Decisions Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-380047","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lilly to Participate in Bernstein Operational Decisions Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lilly to Participate in Bernstein Operational Decisions Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire INDIANAPOLIS, Nov. 12, 2020 \/PRNewswire\/ &#8212;\u00a0Eli Lilly and Company (NYSE:LLY) will participate in the Bernstein Operational Decisions Conference on Monday, November 16, 2020. Andrew Adams, Ph.D., vice president of new therapeutic modalities and scientific leader for Lilly&#8217;s anti-COVID-19 platform, Jeff Emmick, M.D., Ph.D., vice president of diabetes product development, and Mark Mintun, M.D., vice president of pain and neurodegeneration research and president of Avid Radiopharmaceuticals, will participate in a virtual fireside chat at 11:00\u00a0a.m., Eastern Time. A live audio webcast will be available on the &#8220;Webcasts &amp; Presentations&#8221; section of Lilly&#8217;s Investor website at https:\/\/investor.lilly.com\/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days. About\u00a0Eli Lilly and CompanyLilly is a global &hellip; Continue reading &quot;Lilly to Participate in Bernstein Operational Decisions Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T17:33:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-to-participate-in-bernstein-operational-decisions-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-to-participate-in-bernstein-operational-decisions-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lilly to Participate in Bernstein Operational Decisions Conference\",\"datePublished\":\"2020-11-12T17:33:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-to-participate-in-bernstein-operational-decisions-conference\\\/\"},\"wordCount\":270,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-to-participate-in-bernstein-operational-decisions-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/458388\\\/Eli_Lilly_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-to-participate-in-bernstein-operational-decisions-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-to-participate-in-bernstein-operational-decisions-conference\\\/\",\"name\":\"Lilly to Participate in Bernstein Operational Decisions Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-to-participate-in-bernstein-operational-decisions-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-to-participate-in-bernstein-operational-decisions-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/458388\\\/Eli_Lilly_Logo.jpg\",\"datePublished\":\"2020-11-12T17:33:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-to-participate-in-bernstein-operational-decisions-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-to-participate-in-bernstein-operational-decisions-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-to-participate-in-bernstein-operational-decisions-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/458388\\\/Eli_Lilly_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/458388\\\/Eli_Lilly_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lilly-to-participate-in-bernstein-operational-decisions-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lilly to Participate in Bernstein Operational Decisions Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lilly to Participate in Bernstein Operational Decisions Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/","og_locale":"en_US","og_type":"article","og_title":"Lilly to Participate in Bernstein Operational Decisions Conference - Market Newsdesk","og_description":"PR Newswire INDIANAPOLIS, Nov. 12, 2020 \/PRNewswire\/ &#8212;\u00a0Eli Lilly and Company (NYSE:LLY) will participate in the Bernstein Operational Decisions Conference on Monday, November 16, 2020. Andrew Adams, Ph.D., vice president of new therapeutic modalities and scientific leader for Lilly&#8217;s anti-COVID-19 platform, Jeff Emmick, M.D., Ph.D., vice president of diabetes product development, and Mark Mintun, M.D., vice president of pain and neurodegeneration research and president of Avid Radiopharmaceuticals, will participate in a virtual fireside chat at 11:00\u00a0a.m., Eastern Time. A live audio webcast will be available on the &#8220;Webcasts &amp; Presentations&#8221; section of Lilly&#8217;s Investor website at https:\/\/investor.lilly.com\/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days. About\u00a0Eli Lilly and CompanyLilly is a global &hellip; Continue reading \"Lilly to Participate in Bernstein Operational Decisions Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T17:33:35+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lilly to Participate in Bernstein Operational Decisions Conference","datePublished":"2020-11-12T17:33:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/"},"wordCount":270,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/","name":"Lilly to Participate in Bernstein Operational Decisions Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg","datePublished":"2020-11-12T17:33:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/458388\/Eli_Lilly_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lilly-to-participate-in-bernstein-operational-decisions-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lilly to Participate in Bernstein Operational Decisions Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380047","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=380047"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380047\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=380047"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=380047"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=380047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}